Home/Filings/4/0000935836-25-000416
4//SEC Filing

Hively Brad 4

Accession 0000935836-25-000416

CIK 0001799191other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 6:51 PM ET

Size

21.8 KB

Accession

0000935836-25-000416

Insider Transaction Report

Form 4
Period: 2025-06-03
Hively Brad
Director
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-06-03+131,2970 total
    Exercise: $1.87Exp: 2032-11-17Common Stock (131,297 underlying)
  • Sale

    Common Stock

    2025-06-03$2.87/sh1,867,605$5,360,587712,033 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-06-03+105,3200 total
    Exercise: $0.48Exp: 2033-03-17Common Stock (105,320 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-06-03+946,4600 total
    Exercise: $0.85Exp: 2029-12-02Common Stock (946,460 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-03$0.85/sh+684,528$581,8491,396,561 total
  • Exercise/Conversion

    Common Stock

    2025-06-03$0.48/sh+105,320$50,6591,501,881 total
  • Exercise/Conversion

    Common Stock

    2025-06-03$1.87/sh+131,297$245,5251,633,178 total
  • Exercise/Conversion

    Common Stock

    2025-06-03$0.85/sh+946,460$804,4912,579,638 total
  • Sale

    Common Stock

    2025-06-03$2.87/sh108,532$311,519603,501 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-06-03+684,5280 total
    Exercise: $0.85Exp: 2029-12-02Common Stock (684,528 underlying)
Footnotes (6)
  • [F1]Represents sale of Common Stock acquired from previously vested RSU awards.
  • [F2]These options vested monthly for 36 months following November 12, 2021.
  • [F3]These options vested monthly starting March 17, 2023, with cancellation of remaining options pursuant to Note 6 below.
  • [F4]These options vested monthly starting November 17, 2022, with cancellation of remaining options pursuant to Note 6 below.
  • [F5]These options vested monthly for 48 months following December 2, 2019.
  • [F6]Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024.

Documents

1 file

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother

Related Parties

1
  • filerCIK 0001891124

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:51 PM ET
Size
21.8 KB